Rotigotine transdermal patch: Clinical Trials

4 trials of Rotigotine transdermal patch, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Rotigotine transdermal patch: new trials by email Literature Review of Rotigotine transdermal patch trials Research Report on Rotigotine transdermal patch

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
Rotigotine transdermal patch - Parkinson's Disease
Phase 1CompletedUCB Pharma562011-04-012011-08-30
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Rotigotine transdermal patch - Healthy Volunteers
Phase 1CompletedUCB Pharma502010-01-012012-05-22
Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.
Rotigotine transdermal patch - Healthy
Phase 1CompletedUCB Pharma522008-10-012014-10-27
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Rotigotine transdermal patch - Healthy
Phase 1CompletedUCB BIOSCIENCES GmbH502002-10-012014-10-20

Conditions studied

Parkinson Disease (1)

Sponsors

UCB Pharma (3)  ·  UCB BIOSCIENCES GmbH (1)

Countries

Germany (4)  ·  Austria (1)  ·  United Kingdom (1)

Results publications

PMID 24006953